The vision of the Snowdome Foundation is to ensure every Australian blood cancer
patient has the best opportunity for a cure, and this starts with a correct diagnosis.
We collaborate with world-leading Australian and international blood cancer researchers
to accelerate new therapies and bring next-generation treatments to patients, faster.
We are the leading not-for-profit organisation focused exclusively on raising funds to
support translational research and clinical trials that will accelerate new treatments
(and cures) to help Australian blood cancer patients live longer, better lives.
Over $53 million has been committed to blood cancer research since 2010.
67 research projects funded enabling over 98 research positions.
Over 6,200 subsidised genomic tests completed at the Wilson Centre for Blood Cancer Genomics.
Enabled 1,817 patients to participate in clinical trials supported by Snowdome.
Latest News

2024 Cannon Family Travel Grant Update | Dr Edward Cliff
2024 Cannon Family Travel Grant recipient, Dr Edward Cliff, a third-year clinical haematology registrar at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital, recently attended the American Society of Haematology (ASH) Annual Meeting in California.
Read more
Myeloma Awareness Month
The Snowdome Foundation collaborates with world-leading blood cancer researchers to accelerate new therapies for Australian myeloma patients.
Read more
Transforming Therapies for Myeloma Patients
Supported by the Snowdome Foundation, A/Prof. Jane Oliaro is undertaking important work to improve the functionality of CAR-T cells for myeloma patients.
Read more